Restatement of Previously Issued Consolidated Financial Statements (Details Narrative) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||
| Inventory, Net | $ (15,616) | $ (8,516) | |
| Inventory Valuation Reserves | 1,657 | 639 | |
| Cost of Product and Service Sold | 39,295 | 30,019 | |
| Income Tax Expense (Benefit) | 227 | 6 | |
| Revision of Prior Period, Error Correction, Adjustment [Member] | |||
| Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||
| Inventory, Net | 4,651 | 1,515 | $ 968 |
| Cost of Product and Service Sold | $ 3,136 | $ 547 | |
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of valuation reserve for inventory. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|